Cannabinoids

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Articles

Cannabis Science Conference West, taking place May 18-20 in Long Beach, California, is quickly approaching. The two-day agenda is packed with exciting speakers from around the country as well as many prominent women moving the industry forward. In honor of Women’s History Month, we connected with Dr. Lakisha Jenkins-Samuels, a traditional naturopath, Dr. Lakisha™️. 

Dietary Modulation and the Endocannabinoid System: A Cannabis Science Conference West Preview with Dr. Lakisha Jenkins-Samuels

As time passes and more research comes to light regarding COVID-19, additional research is also needed for cannabis and its various cannabinoids.  Through new data, cannabis has shown that it has more to offer than the stigma it has been clouded by. In this interview, Inesa Ponomariovaite, founder of Nesas Hemp and a holistic health coach, discusses the untapped medicinal properties of cannabidiolic acid (CBDA) and cannabigerolic acid (CGBA) for COVID-19 prevention and treatment and why CBDA is the top cannabinoid.

CBDA and CBGA Promote Milder COVID-19 Symptoms Among Other Medicinal Health Benefits

David Hodes has written for many cannabis publications, and organized or moderated sessions at national and international cannabis trade shows. He was voted the 2018 Journalist of the Year by Americans for Safe Access, the world’s largest medical cannabis advocacy organization.

The new processed cannabis products continue to attract consumers—but black market influence causes hesitancy.


More Innovative Cannabis Products Emerge Amidst Ongoing Processor Issues

Dr. Richard van Breemen from the Department of Pharmaceutical Sciences in the Oregon State University College of Pharmacy discusses his COVID-19 and cannabis research.

Cannabinoids and COVID-19: An Interview with Professor Richard van Breemen of Oregon State University

This study focuses on a step-by-step optimization of commercial scale preparative HPLC purification of cannabinoids, specifically cannabidiol, starting with stationary reversed-phase screening, followed by method optimization.

Development, Optimization, and Process Performance for Preparative Chromatographic Purification of Cannabinoids

It is demonstrated in this paper that cell viability can be used to determine dose and response effects that are important in understanding toxicities and to detect differences in similar hemp products.

Human Cells Can Be Used to Study Cannabinoid Dosage and Inflammatory Cytokine Responses

Terpenes can be tricky. Although cannabis is heavily regulated, since cannabis-derived terpenes do not contain tetrahydrocannabinol (THC) and other cannabinoids, they are not regulated in the same way that cannabis is. 

Tricky Terpenes: Under-Regulated Use of Added Terpenes in a Regulated Cannabis Industry

In this piece, we touch on the benefits and challenges associated with autoflowering genetics, and provide justification for why these unique varietals may be the catalyst for making cannabis medicine more accessible and approachable for the general population. 

Autoflowering Genetics Present Unique Opportunities

Gb Sciences, recently announced positive results from a study of its cannabinoid-containing mixtures as a potential treatment for cytokine release syndrome (CRS). With the high rate of transmission of the Omicron variant in multiple countries, Gb Sciences team are working to move quickly through the development stages for this novel CRS therapy.

Gb Sciences Shares Potential Cannabinoid-Based COVID-19 Treatment as Omicron Variant Surges Worldwide

Dr. Denise Vidot shares some of her research findings that examine the impact of phytocannabinoids on multiple diseases.